Allogeneic Stem Cell Therapy Market, Global Outlook and Forecast 2024-2031

Report ID: 1068269 | Published Date: Jan 2025 | No. of Page: 67 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Allogeneic Stem Cell Therapy Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Allogeneic Stem Cell Therapy Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Allogeneic Stem Cell Therapy Overall Market Size
    2.1 Global Allogeneic Stem Cell Therapy Market Size: 2021 VS 2028
    2.2 Global Allogeneic Stem Cell Therapy Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Allogeneic Stem Cell Therapy Players in Global Market
    3.2 Top Global Allogeneic Stem Cell Therapy Companies Ranked by Revenue
    3.3 Global Allogeneic Stem Cell Therapy Revenue by Companies
    3.4 Top 3 and Top 5 Allogeneic Stem Cell Therapy Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Allogeneic Stem Cell Therapy Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Allogeneic Stem Cell Therapy Players in Global Market
        3.6.1 List of Global Tier 1 Allogeneic Stem Cell Therapy Companies
        3.6.2 List of Global Tier 2 and Tier 3 Allogeneic Stem Cell Therapy Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Allogeneic Stem Cell Therapy Market Size Markets, 2021 & 2028
        4.1.2 Adult Stem Cell Therapy
        4.1.3 Human Embryonic Stem Cell Therapy
        4.1.4 Induced Pluripotent Stem Cell Therapy
        4.1.5 Others
    4.2 By Type - Global Allogeneic Stem Cell Therapy Revenue & Forecasts
        4.2.1 By Type - Global Allogeneic Stem Cell Therapy Revenue, 2017-2022
        4.2.2 By Type - Global Allogeneic Stem Cell Therapy Revenue, 2023-2028
        4.2.3 By Type - Global Allogeneic Stem Cell Therapy Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Allogeneic Stem Cell Therapy Market Size, 2021 & 2028
        5.1.2 Musculoskeletal Disorder
        5.1.3 Wounds & Injuries
        5.1.4 Cardiovascular Diseases
        5.1.5 Others
    5.2 By Application - Global Allogeneic Stem Cell Therapy Revenue & Forecasts
        5.2.1 By Application - Global Allogeneic Stem Cell Therapy Revenue, 2017-2022
        5.2.2 By Application - Global Allogeneic Stem Cell Therapy Revenue, 2023-2028
        5.2.3 By Application - Global Allogeneic Stem Cell Therapy Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Allogeneic Stem Cell Therapy Market Size, 2021 & 2028
    6.2 By Region - Global Allogeneic Stem Cell Therapy Revenue & Forecasts
        6.2.1 By Region - Global Allogeneic Stem Cell Therapy Revenue, 2017-2022
        6.2.2 By Region - Global Allogeneic Stem Cell Therapy Revenue, 2023-2028
        6.2.3 By Region - Global Allogeneic Stem Cell Therapy Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Allogeneic Stem Cell Therapy Revenue, 2017-2028
        6.3.2 US Allogeneic Stem Cell Therapy Market Size, 2017-2028
        6.3.3 Canada Allogeneic Stem Cell Therapy Market Size, 2017-2028
        6.3.4 Mexico Allogeneic Stem Cell Therapy Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Allogeneic Stem Cell Therapy Revenue, 2017-2028
        6.4.2 Germany Allogeneic Stem Cell Therapy Market Size, 2017-2028
        6.4.3 France Allogeneic Stem Cell Therapy Market Size, 2017-2028
        6.4.4 U.K. Allogeneic Stem Cell Therapy Market Size, 2017-2028
        6.4.5 Italy Allogeneic Stem Cell Therapy Market Size, 2017-2028
        6.4.6 Russia Allogeneic Stem Cell Therapy Market Size, 2017-2028
        6.4.7 Nordic Countries Allogeneic Stem Cell Therapy Market Size, 2017-2028
        6.4.8 Benelux Allogeneic Stem Cell Therapy Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Allogeneic Stem Cell Therapy Revenue, 2017-2028
        6.5.2 China Allogeneic Stem Cell Therapy Market Size, 2017-2028
        6.5.3 Japan Allogeneic Stem Cell Therapy Market Size, 2017-2028
        6.5.4 South Korea Allogeneic Stem Cell Therapy Market Size, 2017-2028
        6.5.5 Southeast Asia Allogeneic Stem Cell Therapy Market Size, 2017-2028
        6.5.6 India Allogeneic Stem Cell Therapy Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Allogeneic Stem Cell Therapy Revenue, 2017-2028
        6.6.2 Brazil Allogeneic Stem Cell Therapy Market Size, 2017-2028
        6.6.3 Argentina Allogeneic Stem Cell Therapy Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Allogeneic Stem Cell Therapy Revenue, 2017-2028
        6.7.2 Turkey Allogeneic Stem Cell Therapy Market Size, 2017-2028
        6.7.3 Israel Allogeneic Stem Cell Therapy Market Size, 2017-2028
        6.7.4 Saudi Arabia Allogeneic Stem Cell Therapy Market Size, 2017-2028
        6.7.5 UAE Allogeneic Stem Cell Therapy Market Size, 2017-2028
7 Players Profiles
    7.1 Escape Therapeutics, Inc.
        7.1.1 Escape Therapeutics, Inc. Corporate Summary
        7.1.2 Escape Therapeutics, Inc. Business Overview
        7.1.3 Escape Therapeutics, Inc. Allogeneic Stem Cell Therapy Major Product Offerings
        7.1.4 Escape Therapeutics, Inc. Allogeneic Stem Cell Therapy Revenue in Global Market (2017-2022)
        7.1.5 Escape Therapeutics, Inc. Key News
    7.2 Lonza Group Ltd.
        7.2.1 Lonza Group Ltd. Corporate Summary
        7.2.2 Lonza Group Ltd. Business Overview
        7.2.3 Lonza Group Ltd. Allogeneic Stem Cell Therapy Major Product Offerings
        7.2.4 Lonza Group Ltd. Allogeneic Stem Cell Therapy Revenue in Global Market (2017-2022)
        7.2.5 Lonza Group Ltd. Key News
    7.3 Osiris Therapeutics (Smith & Nephew)
        7.3.1 Osiris Therapeutics (Smith & Nephew) Corporate Summary
        7.3.2 Osiris Therapeutics (Smith & Nephew) Business Overview
        7.3.3 Osiris Therapeutics (Smith & Nephew) Allogeneic Stem Cell Therapy Major Product Offerings
        7.3.4 Osiris Therapeutics (Smith & Nephew) Allogeneic Stem Cell Therapy Revenue in Global Market (2017-2022)
        7.3.5 Osiris Therapeutics (Smith & Nephew) Key News
    7.4 NuVasive
        7.4.1 NuVasive Corporate Summary
        7.4.2 NuVasive Business Overview
        7.4.3 NuVasive Allogeneic Stem Cell Therapy Major Product Offerings
        7.4.4 NuVasive Allogeneic Stem Cell Therapy Revenue in Global Market (2017-2022)
        7.4.5 NuVasive Key News
    7.5 Chiesi Pharmaceuticals
        7.5.1 Chiesi Pharmaceuticals Corporate Summary
        7.5.2 Chiesi Pharmaceuticals Business Overview
        7.5.3 Chiesi Pharmaceuticals Allogeneic Stem Cell Therapy Major Product Offerings
        7.5.4 Chiesi Pharmaceuticals Allogeneic Stem Cell Therapy Revenue in Global Market (2017-2022)
        7.5.5 Chiesi Pharmaceuticals Key News
    7.6 JCR Pharmaceutical
        7.6.1 JCR Pharmaceutical Corporate Summary
        7.6.2 JCR Pharmaceutical Business Overview
        7.6.3 JCR Pharmaceutical Allogeneic Stem Cell Therapy Major Product Offerings
        7.6.4 JCR Pharmaceutical Allogeneic Stem Cell Therapy Revenue in Global Market (2017-2022)
        7.6.5 JCR Pharmaceutical Key News
    7.7 Pharmicell
        7.7.1 Pharmicell Corporate Summary
        7.7.2 Pharmicell Business Overview
        7.7.3 Pharmicell Allogeneic Stem Cell Therapy Major Product Offerings
        7.7.4 Pharmicell Allogeneic Stem Cell Therapy Revenue in Global Market (2017-2022)
        7.7.5 Pharmicell Key News
    7.8 Anterogen
        7.8.1 Anterogen Corporate Summary
        7.8.2 Anterogen Business Overview
        7.8.3 Anterogen Allogeneic Stem Cell Therapy Major Product Offerings
        7.8.4 Anterogen Allogeneic Stem Cell Therapy Revenue in Global Market (2017-2022)
        7.8.5 Anterogen Key News
    7.9 MolMed S.p.A.
        7.9.1 MolMed S.p.A. Corporate Summary
        7.9.2 MolMed S.p.A. Business Overview
        7.9.3 MolMed S.p.A. Allogeneic Stem Cell Therapy Major Product Offerings
        7.9.4 MolMed S.p.A. Allogeneic Stem Cell Therapy Revenue in Global Market (2017-2022)
        7.9.5 MolMed S.p.A. Key News
    7.10 Takeda (TiGenix)
        7.10.1 Takeda (TiGenix) Corporate Summary
        7.10.2 Takeda (TiGenix) Business Overview
        7.10.3 Takeda (TiGenix) Allogeneic Stem Cell Therapy Major Product Offerings
        7.10.4 Takeda (TiGenix) Allogeneic Stem Cell Therapy Revenue in Global Market (2017-2022)
        7.10.5 Takeda (TiGenix) Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Allogeneic Stem Cell Therapy Market Opportunities & Trends in Global Market
    Table 2. Allogeneic Stem Cell Therapy Market Drivers in Global Market
    Table 3. Allogeneic Stem Cell Therapy Market Restraints in Global Market
    Table 4. Key Players of Allogeneic Stem Cell Therapy in Global Market
    Table 5. Top Allogeneic Stem Cell Therapy Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Allogeneic Stem Cell Therapy Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Allogeneic Stem Cell Therapy Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Allogeneic Stem Cell Therapy Product Type
    Table 9. List of Global Tier 1 Allogeneic Stem Cell Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Allogeneic Stem Cell Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Allogeneic Stem Cell Therapy Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Allogeneic Stem Cell Therapy Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Allogeneic Stem Cell Therapy Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Allogeneic Stem Cell Therapy Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Allogeneic Stem Cell Therapy Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Allogeneic Stem Cell Therapy Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2023-2028
    Table 30. Escape Therapeutics, Inc. Corporate Summary
    Table 31. Escape Therapeutics, Inc. Allogeneic Stem Cell Therapy Product Offerings
    Table 32. Escape Therapeutics, Inc. Allogeneic Stem Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 33. Lonza Group Ltd. Corporate Summary
    Table 34. Lonza Group Ltd. Allogeneic Stem Cell Therapy Product Offerings
    Table 35. Lonza Group Ltd. Allogeneic Stem Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 36. Osiris Therapeutics (Smith & Nephew) Corporate Summary
    Table 37. Osiris Therapeutics (Smith & Nephew) Allogeneic Stem Cell Therapy Product Offerings
    Table 38. Osiris Therapeutics (Smith & Nephew) Allogeneic Stem Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 39. NuVasive Corporate Summary
    Table 40. NuVasive Allogeneic Stem Cell Therapy Product Offerings
    Table 41. NuVasive Allogeneic Stem Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 42. Chiesi Pharmaceuticals Corporate Summary
    Table 43. Chiesi Pharmaceuticals Allogeneic Stem Cell Therapy Product Offerings
    Table 44. Chiesi Pharmaceuticals Allogeneic Stem Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 45. JCR Pharmaceutical Corporate Summary
    Table 46. JCR Pharmaceutical Allogeneic Stem Cell Therapy Product Offerings
    Table 47. JCR Pharmaceutical Allogeneic Stem Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 48. Pharmicell Corporate Summary
    Table 49. Pharmicell Allogeneic Stem Cell Therapy Product Offerings
    Table 50. Pharmicell Allogeneic Stem Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 51. Anterogen Corporate Summary
    Table 52. Anterogen Allogeneic Stem Cell Therapy Product Offerings
    Table 53. Anterogen Allogeneic Stem Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 54. MolMed S.p.A. Corporate Summary
    Table 55. MolMed S.p.A. Allogeneic Stem Cell Therapy Product Offerings
    Table 56. MolMed S.p.A. Allogeneic Stem Cell Therapy Revenue (US$, Mn), (2017-2022)
    Table 57. Takeda (TiGenix) Corporate Summary
    Table 58. Takeda (TiGenix) Allogeneic Stem Cell Therapy Product Offerings
    Table 59. Takeda (TiGenix) Allogeneic Stem Cell Therapy Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Allogeneic Stem Cell Therapy Segment by Type in 2021
    Figure 2. Allogeneic Stem Cell Therapy Segment by Application in 2021
    Figure 3. Global Allogeneic Stem Cell Therapy Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Allogeneic Stem Cell Therapy Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Allogeneic Stem Cell Therapy Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Allogeneic Stem Cell Therapy Revenue in 2021
    Figure 8. By Type - Global Allogeneic Stem Cell Therapy Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Allogeneic Stem Cell Therapy Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Allogeneic Stem Cell Therapy Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Allogeneic Stem Cell Therapy Revenue Market Share, 2017-2028
    Figure 12. US Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Allogeneic Stem Cell Therapy Revenue Market Share, 2017-2028
    Figure 16. Germany Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 17. France Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Allogeneic Stem Cell Therapy Revenue Market Share, 2017-2028
    Figure 24. China Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 28. India Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Allogeneic Stem Cell Therapy Revenue Market Share, 2017-2028
    Figure 30. Brazil Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Allogeneic Stem Cell Therapy Revenue Market Share, 2017-2028
    Figure 33. Turkey Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Allogeneic Stem Cell Therapy Revenue, (US$, Mn), 2017-2028
    Figure 37. Escape Therapeutics, Inc. Allogeneic Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. Lonza Group Ltd. Allogeneic Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Osiris Therapeutics (Smith & Nephew) Allogeneic Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. NuVasive Allogeneic Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Chiesi Pharmaceuticals Allogeneic Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. JCR Pharmaceutical Allogeneic Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Pharmicell Allogeneic Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Anterogen Allogeneic Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. MolMed S.p.A. Allogeneic Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Takeda (TiGenix) Allogeneic Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
67
Frequently Asked Questions
Allogeneic Stem Cell Therapy Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Allogeneic Stem Cell Therapy Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Allogeneic Stem Cell Therapy Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports